Global Glycomics/Glycobiology Market Size study & Forecast, by Product (Enzymes, Instruments, Kits, Carbohydrates, Reagents), Application (Drug Discovery, Diagnostics), End User and Regional Forecasts 2025-2035

Description

The Global Glycomics/Glycobiology Market, currently valued at approximately USD 2.4 billion in 2024, is projected to expand at an impressive CAGR of 15.50% between 2025 and 2035, reaching USD 11.71 billion by the end of the forecast period. Glycomics-the comprehensive study of glycan structures, functions, and biology-has rapidly emerged as a transformative field in biotechnology, shaping advancements in diagnostics, drug discovery, and personalized medicine. The demand for glycomics solutions has surged in parallel with the growing understanding that glycans play a critical role in disease mechanisms, immune modulation, and therapeutic targeting. Increasing funding from public and private sectors, coupled with technological breakthroughs in analytical tools such as high-resolution mass spectrometry, advanced chromatography, and glycan arrays, is fueling adoption across pharmaceutical companies, research institutes, and diagnostic laboratories. Moreover, the integration of AI-driven bioinformatics into glycan analysis is accelerating biomarker identification and enhancing the precision of therapeutic development.

The market's upward trajectory is also supported by a dramatic shift toward targeted biologics and biosimilars, where glycan characterization is vital for ensuring efficacy and safety. Expanding applications in oncology, infectious diseases, and autoimmune disorders are further driving demand for high-throughput glycomics platforms and reagent kits. According to industry reports, the increasing prevalence of chronic illnesses and the urgent need for novel therapeutics have prompted significant investments into glycoprotein research and structural glycomics. However, despite these promising growth catalysts, the field still faces bottlenecks such as the high cost of advanced analytical instruments, a shortage of skilled glycomics specialists, and the complexity of glycan data interpretation. Nevertheless, ongoing innovations in miniaturized assay systems, improved sample preparation techniques, and automated data processing promise to overcome these challenges, creating fertile ground for market expansion in the coming decade.

Regionally, North America currently leads the global glycomics/glycobiology market, driven by a robust biopharmaceutical industry, world-class research infrastructure, and sustained funding from institutions such as the NIH. The United States, in particular, is home to numerous companies at the forefront of glycan-based drug development and diagnostic innovation. Europe follows closely, propelled by strong academic-industry collaborations, government-backed research programs, and a growing focus on precision medicine initiatives. The Asia Pacific region is expected to witness the fastest growth through 2035, fueled by rapid expansion of life sciences research in countries like China, Japan, and India, coupled with increasing clinical trial activities and biomanufacturing investments. Latin America and the Middle East & Africa are also poised for gradual growth as they build research capacities, attract foreign investments, and integrate advanced glycomics platforms into regional healthcare systems.

Major market player included in this report are:

Thermo Fisher Scientific Inc.
Merck KGaA
Agilent Technologies, Inc.
New England Biolabs
Shimadzu Corporation
Waters Corporation
Bruker Corporation
Danaher Corporation
PerkinElmer Inc.
RayBiotech Life, Inc.
Takara Bio Inc.
Lectenz Bio
Bio-Techne Corporation
S-BIO (Sumitomo Bakelite Co., Ltd.)
Z Biotech LLC

Global Glycomics/Glycobiology Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Product:

Enzymes (Glycosidases, Transferases)
Instruments (Mass Spectrometry, Chromatography, Arrays)
Kits
Carbohydrates
Reagents

By Application:

Drug Discovery
Diagnostics

By End User:

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Diagnostic Laboratories

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Glycomics/Glycobiology Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study (Historical Data - 2023, 2024; Base Year for Estimation - 2024; Forecast period - 2025-2035)

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings

Chapter 3. Global Glycomics/Glycobiology Market Forces Analysis

3.1. Market Forces Shaping The Global Glycomics/Glycobiology Market (2024-2035)
3.2. Drivers
- 3.2.1. Demand for glycan characterization in biologics/biosimilars and increasing biopharma R&D investments
- 3.2.2. Technological breakthroughs in high-resolution mass spectrometry, advanced chromatography, glycan arrays and AI-driven bioinformatics
3.3. Restraints
- 3.3.1. High capital expenditure for advanced analytical instruments and costly reagent/kit ecosystems
- 3.3.2. Shortage of skilled glycomics specialists and complexity of glycan data interpretation slowing adoption
3.4. Opportunities
- 3.4.1. Integration with precision medicine and biomarker discovery for diagnostics and targeted therapeutics
- 3.4.2. Expansion in emerging markets and growth of contract research/outsourced glycomics services

Chapter 4. Global Glycomics/Glycobiology Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Glycomics/Glycobiology Market Size & Forecasts by Product 2025-2035

5.1. Market Overview
5.2. Global Glycomics/Glycobiology Market Performance - Potential Analysis (2025)
5.3. Enzymes (Glycosidases, Transferases)
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Instruments (Mass Spectrometry, Chromatography, Arrays)
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
5.5. Kits
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035
5.6. Carbohydrates
- 5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.6.2. Market size analysis, by region, 2025-2035
5.7. Reagents
- 5.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.7.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Glycomics/Glycobiology Market Size & Forecasts by Application 2025-2035

6.1. Market Overview
6.2. Global Glycomics/Glycobiology Market Performance - Potential Analysis (2025)
6.3. Drug Discovery
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Diagnostics
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Glycomics/Glycobiology Market Size & Forecasts by Region 2025-2035

7.1. Global Glycomics/Glycobiology Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Glycomics/Glycobiology Market
- 7.3.1. U.S. Glycomics/Glycobiology Market
  - 7.3.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.3.1.2. Application breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Glycomics/Glycobiology Market
  - 7.3.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.3.2.2. Application breakdown size & forecasts, 2025-2035
7.4. Europe Glycomics/Glycobiology Market
- 7.4.1. UK Glycomics/Glycobiology Market
  - 7.4.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.1.2. Application breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Glycomics/Glycobiology Market
  - 7.4.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.2.2. Application breakdown size & forecasts, 2025-2035
- 7.4.3. France Glycomics/Glycobiology Market
  - 7.4.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.3.2. Application breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Glycomics/Glycobiology Market
  - 7.4.4.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.4.2. Application breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Glycomics/Glycobiology Market
  - 7.4.5.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.5.2. Application breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Glycomics/Glycobiology Market
  - 7.4.6.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.6.2. Application breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Glycomics/Glycobiology Market
- 7.5.1. China Glycomics/Glycobiology Market
  - 7.5.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.1.2. Application breakdown size & forecasts, 2025-2035
- 7.5.2. India Glycomics/Glycobiology Market
  - 7.5.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.2.2. Application breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Glycomics/Glycobiology Market
  - 7.5.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.3.2. Application breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Glycomics/Glycobiology Market
  - 7.5.4.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.4.2. Application breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Glycomics/Glycobiology Market
  - 7.5.5.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.5.2. Application breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Glycomics/Glycobiology Market
  - 7.5.6.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.6.2. Application breakdown size & forecasts, 2025-2035
7.6. Latin America Glycomics/Glycobiology Market
- 7.6.1. Brazil Glycomics/Glycobiology Market
  - 7.6.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.6.1.2. Application breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Glycomics/Glycobiology Market
  - 7.6.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.6.2.2. Application breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Glycomics/Glycobiology Market
- 7.7.1. UAE Glycomics/Glycobiology Market
  - 7.7.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.1.2. Application breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Glycomics/Glycobiology Market
  - 7.7.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.2.2. Application breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Glycomics/Glycobiology Market
  - 7.7.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.3.2. Application breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Thermo Fisher Scientific Inc.
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Merck KGaA
8.4. Agilent Technologies, Inc.
8.5. New England Biolabs
8.6. Shimadzu Corporation
8.7. Waters Corporation
8.8. Bruker Corporation
8.9. Danaher Corporation
8.10. PerkinElmer Inc.
8.11. RayBiotech Life, Inc.
8.12. Takara Bio Inc.
8.13. Lectenz Bio
8.14. Bio-Techne Corporation
8.15. S-BIO (Sumitomo Bakelite Co., Ltd.)
8.16. Z Biotech LLC